Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.
Carmen M PredaCristian BaicusIrina SandraAlexandru OproiuTeodora ManucIleana ConstantinescuDaniel GavrilaMircea DiculescuRadu DumitruCatalin VasilescuCristian TieranuDoina IstratescuTheodor VoiosuMircea ManucPublished in: United European gastroenterology journal (2019)
DAA therapy significantly reduced the recurrence rate of HCC and improved survival without recurrence in patients with treated HCV-associated HCC.